Cargando…

A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease

BACKGROUND AND PURPOSE: Sickle cell disease (SCD) is a collection of rare inherited blood disorders affecting approximately 100,000 people in the U.S. and 20–25 million people globally. Individuals with SCD experience recurrent episodes of severe and unpredictable pain that are caused by vaso-occlus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaidi, Ahmar U., Glaros, Alexander K., Lee, Soyon, Wang, Taiji, Bhojwani, Rhea, Morris, Eric, Donohue, Breanne, Paulose, Jincy, Iorga, Şerban R., Nellesen, Dave
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561926/ https://www.ncbi.nlm.nih.gov/pubmed/34727959 http://dx.doi.org/10.1186/s13023-021-02096-6

Ejemplares similares

The Burden of Sickle Cell Disease on Children and Their Caregivers: Caregiver Reports of Children’s Health-Related Quality of Life and School Experiences, Caregiver Burden, and Their Association with Frequency of Vaso-Occlusive Crises
por: Campbell, Andrew, et al.
Publicado: (2023)

Evaluation of Vaso-occlusive Crises in United States Sickle Cell Disease Patients: A Retrospective Claims-based Study
por: Shah, Nirmish, et al.
Publicado: (2019)

Association between Vaso-occlusive Crises and Opioid Prescriptions among Patients with Sickle Cell Disease: A Retrospective Claims-based Study
por: Kang, Hyeun Ah, et al.
Publicado: (2020)

Association Between Vaso-Occlusive Crises and Opioid Prescriptions Among Patients with Sickle Cell Disease: A Retrospective Claims-Based Study
por: Kang, Hyeun Ah, et al.
Publicado: (2020)

The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease
por: Rizio, Avery A., et al.
Publicado: (2020)

Longitudinal assessment of adhesion to vascular cell adhesion molecule‐1 at steady state and during vaso‐occlusive crises in sickle cell disease
por: White, Jennell, et al.
Publicado: (2021)

Ketamine for Sickle Cell Vaso-Occlusive Crises: A Systematic Review
por: Alshahrani, Mohammed S., et al.
Publicado: (2021)

Medical Resource Use and Costs of Treating Sickle Cell-related Vaso-occlusive Crisis Episodes: A Retrospective Claims Study
por: Shah, Nirmish, et al.
Publicado: (2020)

The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of Hospitalization due to Vaso-Occlusive Crises
por: Ballas, Samir K.
Publicado: (2017)

Vaso-occlusive crises in patients with sickle cell disease: Parents' perspectives and association with disease outcomes
por: Zolaly, Mohammed, et al.
Publicado: (2019)

Circulating Small Extracellular Vesicles May Contribute to Vaso-Occlusive Crises in Sickle Cell Disease
por: Gemel, Joanna, et al.
Publicado: (2022)

Treatment Options That Reduce the Duration of Sickle Cell Vaso-Occlusive Crises: A Systematic Review
por: Akindele, Adebisi O, et al.
Publicado: (2022)

Impact of hydroxyurea on hospital stay & analgesic utilization in sickle cell anaemia with vaso-occlusive crises
por: Soren, Uttam Kumar, et al.
Publicado: (2022)

Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
por: Udeze, Chuka, et al.
Publicado: (2023)

Severe Painful Vaso-Occlusive Crises and Mortality in a Contemporary Adult Sickle Cell Anemia Cohort Study
por: Darbari, Deepika S., et al.
Publicado: (2013)

Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients
por: Bartolucci, Pablo, et al.
Publicado: (2016)

P-Selectin Blockade in the Treatment of Painful Vaso-Occlusive Crises in Sickle Cell Disease: A Spotlight on Crizanlizumab
por: Karki, Nabin Raj, et al.
Publicado: (2021)

The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell Disease
por: Delgado, Julio, et al.
Publicado: (2021)

Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study
por: Heeney, Matthew M., et al.
Publicado: (2022)

Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
por: Udeze, Chuka, et al.
Publicado: (2023)

PB2511: CLINICAL COMPLICATIONS AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN GERMANY
por: Udeze, Chuka, et al.
Publicado: (2023)

Flow adhesion of whole blood to P‐selectin: a prognostic biomarker for vaso‐occlusive crisis in sickle cell disease
por: Hines, Patrick C., et al.
Publicado: (2021)

Oxygen gradient ektacytometry‐derived biomarkers are associated with vaso‐occlusive crises and correlate with treatment response in sickle cell disease
por: Rab, Minke A. E., et al.
Publicado: (2020)

Shear-Stress-Gradient and Oxygen-Gradient Ektacytometry in Sickle Cell Patients at Steady State and during Vaso-Occlusive Crises
por: Boisson, Camille, et al.
Publicado: (2022)

P1447: MORTALITY AND CLINICAL COMPLICATIONS AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN ITALY
por: Udeze, Chuka, et al.
Publicado: (2023)

Sickle cell vaso-occlusive crisis: it’s a gut feeling
por: Lim, Seah H., et al.
Publicado: (2016)

Whole blood transcriptomic analysis reveals PLSCR4 as a potential marker for vaso-occlusive crises in sickle cell disease
por: Abdulwahab, Hawra, et al.
Publicado: (2021)

The impact of Hydroxyurea on the rates of Vaso–occlusive crises in patients with sickle cell disease in Saudi Arabia: a single–center study
por: Alkhalifah, Sahar Abdullah, et al.
Publicado: (2022)

Effect of Weather on Frequency of Vaso-Occlusive Crisis in Children With Sickle Cell Disease
por: Almuqamam, Mohamed, et al.
Publicado: (2021)

Emerging Therapies for the Management of Pain and Vaso-Occlusive Crises in Patients With Sickle Cell Disease: A Systematic Review of Randomized Controlled Trials
por: Lowe, Michael, et al.
Publicado: (2023)

An Electronic Teaching Module for Improving Knowledge of Self-Management of Vaso-Occlusive Pain Crises in Patients With Sickle Cell Disease: Pilot Questionnaire Study
por: Tam, Tammie, et al.
Publicado: (2019)

The challenge of differentiating vaso-occlusive crises from osteomyelitis in children with sickle cell disease and bone pain: A 15-year retrospective review
por: Fontalis, A., et al.
Publicado: (2019)

Monocyte HLA-DR Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia
por: Fort, Romain, et al.
Publicado: (2022)

Vaso-Occlusion in Sickle Cell Disease: Is Autonomic Dysregulation of the Microvasculature the Trigger?
por: Veluswamy, Saranya, et al.
Publicado: (2019)

S266: DIFFERENT MOLECULAR VASO-OCCLUSIVE TRIGGERS STIMULATE DISTINCT VASO-OCCLUSIVE PROFILES: IN VIVO RESULTS FROM MICE WITH SICKLE CELL ANEMIA
por: Gushiken, Lucas F. S., et al.
Publicado: (2023)

Definity, an affinity for painful crisis: a case series describing vaso-occlusive pain crises in sickle cell patients undergoing echocardiogram with Definity contrast
por: D’Amico, Alex, et al.
Publicado: (2020)

Tranexamic acid use in a patient with sickle cell disease undergoing posterior scoliosis correction surgery: safely mitigating bleeding and vaso-occlusive crises
por: Newall, Millie, et al.
Publicado: (2021)

Voxelotor: alteration of sickle cell disease pathophysiology by a first-in-class polymerization inhibitor
por: Glaros, Alexander K., et al.
Publicado: (2021)

The Role of Infection in the Pathogenesis of Vaso-Occlusive Crisis in Patients with Sickle Cell Disease.
por: Ahmed, Sagir G.
Publicado: (2011)

Defective lipid metabolism in sickle cell anaemia subjects in vaso-occlusive crisis
por: Akinlade, Kehinde Sola, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3u0lf3ns3kpju5t9almtpt56ot